Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-12

Clinical Trial Update: Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances [NA]

View source ↗

Summary

Clinical trial update for a nano-formulation of PSO being investigated for neuroprotection in individuals with a history of psychoactive substance use; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • (Nano PSO)

Snippet

Sponsor: Distribuidora Biolife SA de CV | Conditions: Addiction;Drug(S);LSD, Neuroprotective | NA | Status: RECRUITING